Mutant Calreticulin in the Myeloproliferative Neoplasms. (2020)

First Author: Prins D
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/hs9.0000000000000333

PubMed Identifier: 32382708

Publication URI: http://europepmc.org/abstract/MED/32382708

Type: Journal Article/Review

Volume: 4

Parent Publication: HemaSphere

Issue: 1

ISSN: 2572-9241